Ausgabe 3/2011
Inhalt (9 Artikel)
Analysis of physicians’ perspectives versus patients’ preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma
Axel C. Mühlbacher, Matthias Nübling
Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy
Eberhard Wille, Jürgen Scholze, Eduardo Alegria, Claudio Ferri, Sue Langham, Warren Stevens, David Jeffries, Kerstin Uhl-Hochgraeber
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes
Kristina S. Boye, Louis S. Matza, Kimberly N. Walter, Kate Van Brunt, Andrew C. Palsgrove, Aodan Tynan
Practical issues in handling data input and uncertainty in a budget impact analysis
M. J. C. Nuijten, T. Mittendorf, U. Persson
Deriving reference values and utilities for the QoL-AGHDA in adult GHD
J. J. V. Busschbach, B. H. R. Wolffenbuttel, L. Annemans, W. J. Meerding, M. Kołtowska-Häggström
Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece
Nikos Maniadakis, Mattias Ekman, Vasilios Fragoulakis, Vasiliki Papagiannopoulou, John Yfantopoulos
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
Michael Drummond, Bengt Jönsson, Frans Rutten, Tom Stargardt
Health care costs and their predictors of inflammatory bowel diseases in Germany
Anne Prenzler, Bernd Bokemeyer, J.-Matthias von der Schulenburg, Thomas Mittendorf